Question to the Department of Health and Social Care:
To ask Her Majesty's Government, further to the Written Answer by Parliamentary Under Secretary of State (Minister for Vaccines and Public Health) in the Department of Health and Social Care on 20 April (151279), what level of efficacy against Omicron they would deem as "sufficient" in order to secure a supply of Evusheld.
There is no pre-determined view of a ‘sufficient’ level of efficacy. The Department will seek expert clinical advice on the results of the UK Health Security Agency’s testing to inform future decision making. RAPID C-19 will consider all data relating to the use of Evusheld as a pre-exposure prophylaxis treatment before providing advice to the Chief Medical Officer.